Promote scientific vaccination to prevent cervical cancer

Could deliver the active immunization of older women against cervical cancer a devastating blow against the disease, according to U.S. scientists. According to experts, the active vaccine against cervical cancer could halve cases of the disease in women at the age of about 45 years. Using mathematical calculations, experts estimate that vaccination of women in the U.S. aged 12 to 45 years with cancer-causing HPV may reduce the incidence of cervical cancer by 85% for 12 year olds and up to 55% - for Women 45 years. It could also help to reduce the incidence from 34 to 67% for women 25 years. The calculations on a 100% vaccination of the female population that were based to implement in practice very difficult, experts said. Most cases of cervical cancer caused by the sexually transmitted human papillomavirus. Two U.S. companies have developed a vaccine against HPV types 16 and 18, which are known to cause 70% of cervical cancer cases. Experts hope that the majority of women to participate in the vaccination and avoid the occurrence of a serious illness.